期刊文献+

Synthesis and Crystal Structure of 1′-Methyl-4′- (4-chlorophenyl)-1H-indole-3-spiro-2′-pyrrolidine- 3′-spiro-4''-(2''-phenyloxazole)-2,5''(3H,4''H)-dione

Synthesis and Crystal Structure of 1′-Methyl-4′- (4-chlorophenyl)-1H-indole-3-spiro-2′-pyrrolidine- 3′-spiro-4''-(2''-phenyloxazole)-2,5''(3H,4''H)-dione
下载PDF
导出
摘要 The title compound (C26H20ClN3O3) has been synthesized by 1,3-dipolar cycloaddition reaction from isatin, sarcosine and (Z)-4-(4-chlorobenzylidene)-2-phenyloxazol-5(4H)-one through a one-pot procedure, and its structure was confirmed by IR, IH NMR, elemental analysis and single-crystal X-ray diffraction analysis. The crystal belongs to the triclinic system, space group PI, with a = 9.3903(19), b = 11.398(2), c = 12.603(3) A, α = 83.495(3), β = 68.988(3), γ = 67.178(3)^o, V= 1160.1(4)A^3 Z = 2, Mr= 457.90, Dc= 1.311 g/cm^3, p = 0.198 mm ^-1, F(000) = 476, the final R = 0.0489 and wR = 0.1144 for 3109 observed reflections with I 〉 2σ(I). The title compound (C26H20ClN3O3) has been synthesized by 1,3-dipolar cycloaddition reaction from isatin, sarcosine and (Z)-4-(4-chlorobenzylidene)-2-phenyloxazol-5(4H)-one through a one-pot procedure, and its structure was confirmed by IR, IH NMR, elemental analysis and single-crystal X-ray diffraction analysis. The crystal belongs to the triclinic system, space group PI, with a = 9.3903(19), b = 11.398(2), c = 12.603(3) A, α = 83.495(3), β = 68.988(3), γ = 67.178(3)^o, V= 1160.1(4)A^3 Z = 2, Mr= 457.90, Dc= 1.311 g/cm^3, p = 0.198 mm ^-1, F(000) = 476, the final R = 0.0489 and wR = 0.1144 for 3109 observed reflections with I 〉 2σ(I).
出处 《Chinese Journal of Structural Chemistry》 SCIE CAS CSCD 北大核心 2008年第1期88-92,共5页 结构化学(英文)
基金 Supported by the National Natural Science Foundation of China (No. 20572057) Natural Science Foundation of Shandong Province (Y2006B11)
关键词 ISATIN OXAZOLIDINONE 1 3-dipolar cydoaddition MCRS crystal structure isatin, oxazolidinone, 1,3-dipolar cydoaddition, MCRs, crystal structure
  • 相关文献

参考文献19

  • 1Kobayashi,J.; Tsuda,M.; Agemi,K.; Shigemori,H.; Ishibashi,M.Tetrahedron 1991,47,6617-6622.
  • 2James,D.M.; Kunze,H.B.; Paulkner,D.J.J.Nat..Prod.1991,54,1137-1140.
  • 3Miltyk,W.; Palka,J.A.Comp.Biochem.Physiol.,A 2000,125,265-271.
  • 4Stapon,A.; Li,R.; Townsend,C.A.J.Am.Chem.Soc.2003,125,8486-8493.
  • 5Chan,S.C.; Dong,T.K.; Jiao,Q.Z.J Heterocyclic Chem.2002,39,421-423.
  • 6Ashok,R.Drugs of the Future 2003,28,1070-1077.
  • 7Steven,D.; Paget,C.M.; Boggs,B.D.; Foleno,R.M.; Goldschmidt,D.J.; Hlasta,M.A.; Weidner-Wells,H.M.; Werbloo,K.B.; Mark,J.M.Bio.& Med.Chem.Lett.2006,16,4537-4542.
  • 8Vara,P.; Frederick,E.; Boyer,L.C.Bio.& Med.Chem.Lett.2006,16,5392-5397.
  • 9Xie,W.L.; Ma,L.; Cuo,G.J.; Duan,Z.F.; Chen,M.Chinese.J.Org.Chem.2002,22,999-1003.
  • 10Caramella,P.; Grunanger,P.1,3.Dipolar Cycloaddition Chemistry,Wiley Press:New York 1984.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部